#Arcview Investor Forum in Vancouver
B.C Talks #Cannabis with Leading Experts; Global Legal Market Forecasted to Reach
$57 Billion in Next Ten Years
Stocks Included: (NASDAQ: $CRON),
(CSE: $HIKU.C) , (CSE: $RQB.C)
Pt. Roberts, WA; Delta, BC – May 8, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks, releases an
exclusive video reel of the recently held Arcview Investor Forum in Vancouver
B.C
Read this news in full at http://www.investorideas.com/news/2018/cannabis/05081Arcview.asp
More than 200 high-net worth global investors
gathered at The Westin Bayshore for a two-day forum on Tuesday, May 1st and
Wednesday, May 2nd, hosted for members of The Arcview Investor Network. High
net worth accredited investors will be reviewing pitches from companies who competed
fiercely for a slot out of a field of hundreds of applicants. In 2017 alone, ArcView’s
members placed more than $50 million in 60+ Arcview-curated companies, making
them the top source of capital for the cannabis industry
The teaser reel includes interview
clips of Troy Dayton from Arcview Group , Mike Gorenstein, CEO of the Cronos
Group (NASDAQ: CRON), the first
NASDAQ listed cannabis stock , Alan Gertner, CEO of Hiku Brands (CSE: HIKU) , BDS Analytics, Electrum Partners and other experts in the sector.
Troy Dayton from Arcview Group said
in one of the panel openers, “If we are
going to make a move in this space now is the moment. And as a follow up
reminder to that important point, is to trust but verify.”
Alan Gertner, CEO of Hiku Brands (CSE: HIKU) in his panel session said, “Cannabis is a consumer
product. Consumers buy brands and they buy retail. They don’t buy based on the
underlying agricultural input. They
don’t do it coffee and they don’t do it in beer. Starbucks (NASDAQ: SBUX) sells one
quarter of the coffee in North America .and I suspect none of you know
where their coffee comes from and I
guarantee they don’t grow it. We believed from the get-go that cannabis was a
consumer product and we were going to do everything we could to demonstrate
that cause to the world.”
Talking about
how blockchain could play an integral role in the cannabis sector, Peter McCullagh,Founder, Managing Partner at NameTenX
Ventures said , “Our point of view about blockchain is that if you are a
start- up today and you don’t have blockchain in your company or its not in
your roadmap you are out of business in 3-6 years. “
He also said,” This industry (cannabis)
has a chance to the very first native blockchain industry in the world.”
In a panel session with Gerge
Robinson, CEO of RavenQuest BioMed Inc.
(CSE:RQB) (RVVQF) (1IT.F) and other experts, Mike
Gorenstein, CEO of the Cronos Group (NASDAQ: CRON) talks about
the revenue forecast for Canada’s market
and notes that he would be very surprised if the market did not exceed the
projected $4.5 Billion.
Investorideas.com will be releasing a
series of podcasts and videos of individual presenters during the coming week.
About The Arcview Group
Founded in 2010, The Arcview Group is
responsible for a number of groundbreaking ventures in the cannabis industry.
The Arcview Investor Network includes more than 600 accredited investors who
have put more than $160 million behind 170+ companies. Arcview Market Research
publishes the State of Legal Marijuana Markets report, which is the most
oft-cited market data report. In 2015 Arcview became a partner in Canopy, the
first seed-stage mentor-driven business accelerator. Arcview is also co-founder
of Cannasure Insurance Services, the leading provider of business insurance to
the cannabis industry.
Arcview Group is listed on the 420
directory at Investorideas.com
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer: This directory
is not a recommendation to buy or sell securities or products or services
Investorideas.com charges a fee for placement. The directory is not an
endorsement or recommendation but meant to be an investor resource/ due
diligence tool.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and followers.
More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Arcview
is on the 420 directory – read more at www.420cannabisinvestorideas.com
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Contact Investorideas.com
800-665-0411
No comments:
Post a Comment